Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
Status:
Completed
Trial end date:
2001-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Estrogen can stimulate the growth of endometrial cancer cells. Hormone therapy
using arzoxifene hydrochloride may fight the endometrial cancer by blocking the use of
estrogen by the tumor cells
PURPOSE: This phase II trial is studying how well arzoxifene hydrochloride works in treating
women with recurrent, advanced, or metastatic endometrial cancer.